secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kimball Electronics, Inc. (KE)
CIK:        0001606757
Form:       8-K
Filed at:   2026-07-01T11:20:21+00:00
Accession:  0001606757-26-000028
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kimball Electronics acquires Helvoet for €90M (~$103M); establishes global medical CDMO platform
--------------------------------------------------------------------------------

- Purchase price €90M (~$103M); funded with cash and existing credit lines; closed July 1, 2026.
- Helvoet is a medical CDMO specializing in micro-molding, microfluidics, diagnostics, drug delivery; 2025 revenue ~$56M, EBITDA margin mid-teens.
- Transaction valued at ~9x estimated 2026 adjusted EBITDA; expected to be accretive to fiscal 2027 adjusted earnings.
- Helvoet CEO Eveline Hogenkamp to remain; operations in Netherlands and India; complements Kimball's Indianapolis facility.
- Acquisition establishes global medical CMO platform; expands European and India footprint; blue-chip customer base.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606757/000160675726000028/0001606757-26-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606757/000160675726000028/ke-20260626.htm
  HTML page:      https://secwatch.observer/filing/0001606757-26-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer